Plain-English translation of NCT05136703 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Depression research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study is testing a type of therapy called Cognitive-Behavioral Therapy for Adherence and Depression (CBT-AD) in people living with HIV who are experiencing depression. Researchers want to understand how this talk therapy might improve both mood and the body's immune system by studying changes in the gut bacteria and brain activity. The study will compare people who receive this therapy right away to people who wait six months before starting it.
Depression is very common in people with HIV and can make it harder to take HIV medications consistently. Scientists believe that this treatment might work by changing how the gut and brain communicate, which could help reduce inflammation and improve overall health—but they need to study this carefully to understand how it works.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll first complete baseline visits that include brain scans and blood tests. Then you'll be randomly assigned to either start the therapy right away or wait six months. If you start immediately, you'll attend up to 15 one-on-one therapy sessions over four months, plus one session focused on HIV medication adherence. Throughout the study, researchers will collect blood samples and do brain scans to see how the therapy affects your brain activity, gut health, and immune system. The entire process takes about six to twelve months depending on which group you're in.
AI-generated summary from trial data · Jun 29, 2026 · Not medical advice
United States